Standout Papers

2019 ACC/AHA Guideline ... 1998 2026 2007 2016 3.5k
  1. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2019)
    Donna K. Arnett, Roger S. Blumenthal et al. Circulation
  2. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2019)
    Donna K. Arnett, Roger S. Blumenthal et al. Circulation
  3. Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy (2002)
    Deborah Grady, David Herrington et al. JAMA
  4. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (2019)
    Donna K. Arnett, Roger S. Blumenthal et al. Journal of the American College of Cardiology
  5. Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction (1998)
    Kathérine C. Wu, Elias A. Zerhouni et al. Circulation
  6. Assessment of Coronary Artery Disease by Cardiac Computed Tomography (2006)
    Matthew J. Budoff, Stephan Achenbach et al. Circulation
  7. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary (2019)
    Donna K. Arnett, Roger S. Blumenthal et al. Journal of the American College of Cardiology
  8. Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile (2013)
    Seth S. Martin, Michael J. Blaha et al. JAMA
  9. Diagnostic and Prognostic Value of Absence of Coronary Artery Calcification (2009)
    Ammar Sarwar, Leslee J. Shaw et al. JACC. Cardiovascular imaging
  10. High-Sensitivity C-Reactive Protein and Cardiovascular Disease (2013)
    Omair Yousuf, Bibhu D. Mohanty et al. Journal of the American College of Cardiology
  11. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology (2019)
    Donald M. Lloyd‐Jones, Lynne T. Braun et al. Circulation
  12. An Analysis of Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort (2015)
    Andrew P. DeFilippis, Rebekah Young et al. Annals of Internal Medicine
  13. Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease (2016)
    Michael J. Blaha, Miguel Cainzos‐Achirica et al. Circulation
  14. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013 (2016)
    Joseph Salami, Haider J. Warraich et al. JAMA Cardiology
  15. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study (2021)
    Renato Quispe, Seth S. Martin et al. European Heart Journal
  16. Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease (2019)
    Erin D. Michos, John W. McEvoy et al. New England Journal of Medicine
  17. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis (2021)
    Safi U. Khan, Ahmad Naeem Lone et al. EClinicalMedicine
  18. Cardiovascular Disease Risk Among Cancer Survivors (2022)
    Roberta Florido, Natalie Daya et al. Journal of the American College of Cardiology
  19. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk (2022)
    Anurag Mehta, Nestor Vasquez et al. Journal of the American College of Cardiology

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 82 standout
Sub-graph 1 of 20

Citing Papers

Lipoprotein(a) and cardiovascular disease
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
12 intermediate papers

Works of Roger S. Blumenthal being referenced

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
Roger S. Blumenthal 19874 11826 10400 745 43.0k
Philip Greenland 19627 12931 8415 446 43.6k
C. Noel Bairey Merz 22132 16249 10438 584 43.3k
John A. Spertus 39342 14490 8740 1.1k 64.8k
Michael Pencina 12517 9248 4480 324 34.8k
Michael J. Blaha 11288 7309 7521 748 25.8k
Donald M. Lloyd‐Jones 33587 17512 6181 716 66.3k
Kiang Liu 13137 8878 4961 483 37.9k
Joseph M. Massaro 22006 11083 4065 404 46.0k
Gregory L. Burke 21094 7972 7773 344 55.8k
Nanette K. Wenger 19927 10111 5682 360 34.7k

All Works

Loading papers...

Rankless by CCL
2026